WOCKHARDT
|
The Current P/E Ratio of WOCKHARDT is -435.79.
Share Price | ₹1,528.6 | Jun 05,2025 |
Market Cap | ₹24,839.8 Cr | |
Earnings-TTM | ₹-57.0 Cr | TTM-Consolidated Results |
Price/Earnings | -435.79x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of WOCKHARDT
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹24,839.8 Cr] as on Jun 05,2025
(/) Earnings [ ₹-57.0 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ -435.79x ]
Thus, for WOCKHARDT , the investors are currently willing to pay -435.79 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of WOCKHARDT !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of WOCKHARDT over the last five years.
Historical PE (Price/Earnings) ratio chart of WOCKHARDT
PE Ratio Performance Analysis for WOCKHARDT
- WOCKHARDT 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 1.22x.
- WOCKHARDT 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, WOCKHARDT 's p/e ratio peaked in Mar2021 at 6.12x.
- WOCKHARDT 's p/e ratio hit its five-year low in Mar2024 of 0x.
How does WOCKHARDT 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
WOCKHARDT | -57.00 | -435.79 | 24,839.8 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 10,980.10 | 36.78 | 403,868.0 |
DIVIS LABORATORIES LTD | 2,191.00 | 80.33 | 176,010.0 |
CIPLA LTD | 5,291.05 | 22.74 | 120,318.0 |
TORRENT PHARMACEUTICALS LTD | 1,911.00 | 55.68 | 106,406.0 |
DR REDDYS LABORATORIES LTD | 5,703.50 | 18.87 | 107,644.0 |
MANKIND PHARMA LTD | 2,003.22 | 48.64 | 97,442.0 |
ZYDUS LIFESCIENCES LTD | 4,614.80 | 20.84 | 96,155.7 |
LUPIN LTD | 3,306.26 | 27.56 | 91,124.5 |
AUROBINDO PHARMA LTD | 3,515.26 | 19.16 | 67,344.0 |
ABBOTT INDIA LTD | 1,414.44 | 47.62 | 67,360.2 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs WOCKHARDT 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | -435.79x |
Max industry PE | 80.33x |
Median industry PE | 27.56x |
Average industry PE | -5.23x |
You may also like the below Video Courses